Thursday 27 February, 2020
17:00-18:30 Registries on glomerular diseases
Chairpersons: Theophanis Apostolou, Marten Segelmark
Biopsy registries, Marten Segelmark
IgA nephropathy: Data from the Registry of Hellenic Society of Nephrology, Marios Papasotiriou
Membranous nephropathy: Data from the Registry of Hellenic Society of Nephrology, Maria Stangou
18:30-19:00 Focal segmental glomerulosclerosis
Chairpersons: Dimitrios Goumenos, Vasilios Liakopoulos
Differentiating primary, genetic and secondary FSGS, Fernando Fervenza
19:15-20:45 IgA nephropathy
Chairpersons: Dimitrios Goumenos, Rosanna Coppo
A detective control of complement regulation in IgA nephropathy, Rosana Coppo
Novel treatment for IgA nephropathy: the case for complement inhibition, Annette Bruchfeld
How to assess the risk of progression of IgA nephropathy, Rosana Coppo
Friday 28 February, 2020
8:30-9:30 C3, Interstitial nephritis
Chairpersons: Evangelos Papachristou, Gema Fernandez
Update on C3 glomerulopathy, Kultigin Turkmen
Treatment of acute tubulointerstitial nephritis, Gema Fernandez
9:30-11:00 Membranous nephropathy /Monoclonal gammopathies
Chairpersons: Aikaterini Papagianni, Fernando Fervenza
New antigens in membranous nephropathy, Sanjeev Sethi
Monoclonal gammopathy-associated renal diseases, Sanjeev Sethi
Membranous nephropathy – what have we learned from MENTOR?, Fernando Fervenza
11:15-12:45 Vasculitides
Chairpersons: Ploumis Passadakis, Rodrigo Cartin-Ceba
Differences in epidemiology, prognosis and treatment of ANCA associated vasculitis, Rodrigo Cartin-Ceba
Kidney involvement in ANCA associated vasculitis, Sophia Lionaki
The role of complement in ANCA Associated Vasculitis (AAV), Vladimir Tesar
12:45-13:45 Thrombotic microangiopathies / hemodialysis
Chairpersons: Stylianos Panagoutsos, Kultigin Turkmen
Atypical Hemolytic Uremic Syndrome (aHUS), Vladimir Tesar
Infectious complications of dialysis, An De Vriese
15:45-17:15 Other glomerular diseases
Chairpersons: Elias Thodis, Dario Roccatello
An update on Anti-GBM disease, Marten Segelmark
HCV-associated glomerulonephritis/vasculitis: current treatment considerations in the era of direct antiviral drugs, Annette Bruchfeld
Treatment of cryoglobulinemic nephritis, Dario Roccatello
17:15-18:45 Kidney transplantation
Chairpersons: Ioannis N. Boletis, Annette Bruchfeld
Practical guide to interpreting donor specific antibodytesting in the current era, Carrie Schinstock
Making sense of the varied presentations of antibody mediated rejection in the renal allograft, Carrie Schinstock
Ischemia and reperfusion injury in transplantation, Cees van Kooten
Saturday 29 February, 2020
8:30-10:30 Polycystic kidney disease
Chairpersons: Eugenios Dafnis, Fouad Chebib
Prognostication in ADPKD, Fouad Chebib
Clinical implications of genetic testing in ADPKD patients, Emile Cornec Le Gall
The role of genetic modifiers and molecular interactions in ARPKD diagnosis and prognosis, Paraskevi Goggolidou
Advances in management of patients with ADPKD, Fouad Chebib
10:45-12:15 Lupus nephritis
Chairpersons: Ioannis N. Boletis, Vladimir Tesar
New insights in the pathogenesis of lupus nephritis, Eleni Frangou
New treatment strategies in lupus nephritis, Ladan Zand
New avenues in lupus nephritis (clinical lecture), Hans Joachim Anders
12:15-13:45 Monoclonal gammopathie / Membranous nephropathy
Chairpersons: Dimitrios Vlachakos, Ladan Zand
Reappraisal of AntiPLA2R antibodies in serum and kidney tissue of patients with membranous nephropathy, Dimitrios Goumenos
Cast nephropathy, Vladimir Tesar
Monoclonal gammopathy of renal significance: whento do renal biopsy and how to treat?, Ladan Zand
16:00-17:15 Chronic kidney disease
Chairpersons: Ioannis Stefanidis, Antonello Pani
Prevalence of CKD and its relationship to eGFR-related genetic loci and clinical risk factors in a general population (the SardiNIA study cohort), Antonello Pani
The role of hypertension, proteinuria and dietary protein consumption in the progression of kidney disease, Pantelis Sarafidis
Kidney size in relation to ageing, gender, renal function, birthweight and chronic kidney disease risk factors ina general population (Aging Kidney), Antonello Pani
17:30-19:00 Pregnancy and kidney
Chairpersons: Aikaterini Papagianni, Andrea Kattah
Preeclampsia: Update on pathogenesis and long-term implications, Andrea Kattah
Pregnancy in women with glomerulonephritis, Kapsia Eleni
Effects of pregnancy on the transplanted kidney, Andrea Kattah
19:00-20:00 Perspectives for novel therapies
Chairpersons: Ploumis Passadakis, Hans Joachim Anders
Targeting podocytes beyond standard-of-care, Hans Joachim Anders
Antifibrotic therapies: where and why in human kidney disease, Dimitrios Goumenos